Press-release for stocks related to vaccine

Prices are updated after-hours

tags : Vaccine crawled time : 06:00

save search

Valneva Initiates Phase 1 Trial of Second-Generation Zika Vaccine Candidate
Published: 2024-03-26 (Crawled : 06:00) - globenewswire.com
DVAX | $11.75 -0.76% -0.77% 1.4M

Health Technology

| -5.92% | O: 0.72% H: 0.4% C: -1.75%
candidate vaccine valneva trial

Press Release: Sanofi announces agreement for potential first-in-class vaccine against extraintestinal pathogenic E. coli
Published: 2023-10-03 (Crawled : 06:00) - globenewswire.com
JNJ | News | $149.56 0.3% 0.0% 9.1M

Health Technology

| -3.49% | O: -0.26% H: 0.53% C: 0.43%
SNY | News | $47.69 1.15% 1.13% 1.7M

Health Technology

| -12.95% | O: -1.41% H: 0.0% C: 0.0%
vaccine potential agreement sanofi

NEC laboratories advances therapeutic cancer vaccine research with new AI model Attentive Variational Information Bottleneck
Published: 2023-07-27 (Crawled : 06:00) - prnewswire.com
NIPNF | $66.9 -52.94% 140

Technology Services

| Email alert Add to watchlist
vaccine cancer research

Bavarian Nordic Enters Agreement with Country in Latin America on the Supply of Monkeypox Vaccines
Published: 2022-10-03 (Crawled : 06:00) - globenewswire.com
JNJ | News | $149.56 0.3% 0.0% 9.1M

Health Technology

| -9.46% | O: -0.6% H: 0.05% C: -0.66%
america monkeypox agreement vaccine

Valneva and VBI Vaccines Announce European Partnership for Marketing and Distribution of PreHevbri®
Published: 2022-09-08 (Crawled : 06:00) - biospace.com/
VBIV | $0.591 -1.99% -2.03% 110K

Health Technology

| -97.68% | O: 1.34% H: 0.94% C: -0.67%
prehevbri valneva partnership distribution vaccine

Bavarian Nordic Receives European Approval of Extension of Vaccine Label to Include Monkeypox
Published: 2022-07-25 (Crawled : 06:00) - globenewswire.com
JNJ | News | $149.56 0.3% 0.0% 9.1M

Health Technology

| -12.84% | O: 0.35% H: 0.0% C: 0.0%
monkeypox label vaccine extension approval

Bavarian Nordic Receives Positive CHMP Opinion on the Extension of Vaccine Label to Include Monkeypox
Published: 2022-07-22 (Crawled : 06:00) - globenewswire.com
JNJ | News | $149.56 0.3% 0.0% 9.1M

Health Technology

| -12.04% | O: 0.91% H: 0.0% C: 0.0%
monkeypox label chmp vaccine extension positive

Press Release: Sanofi-GSK first to report a successful efficacy study against Omicron with COVID-19 Beta-containing vaccine
Published: 2022-06-24 (Crawled : 06:00) - globenewswire.com
SNYNF | News | $92.7 -2.18% 600K

Health Technology

| -2.58% | O: 8.01% H: 0.0% C: 0.0%
SNY | News | $47.69 1.15% 1.13% 1.7M

Health Technology

| -7.11% | O: 3.49% H: 0.0% C: 0.0%
covid-19 report vaccine

Valneva and Pfizer Enter into an Equity Subscription Agreement and Update Terms of Collaboration Agreement for Lyme Disease Vaccine Candidate VLA15
Published: 2022-06-20 (Crawled : 06:00) - globenewswire.com
PFE | News 4 | $26.32 0.23% 0.0% 24M

Health Technology

| Email alert Add to watchlist
vla15 valneva disease collaboration vaccine agreement update

Bavarian Nordic Enters a New Multi-Year Vaccine Contract with the Government of Canada
Published: 2022-06-07 (Crawled : 06:00) - globenewswire.com
JNJ | News | $149.56 0.3% 0.0% 9.1M

Health Technology

| -15.57% | O: -0.18% H: 0.0% C: 0.0%
multi-year vaccine canada contract

Bavarian Nordic to Manufacture First Freeze-dried Doses of Smallpox Vaccine upon Exercise of Contract Option by the U.S. Government
Published: 2022-05-18 (Crawled : 06:00) - globenewswire.com
JNJ | News | $149.56 0.3% 0.0% 9.1M

Health Technology

| -16.29% | O: 0.07% H: 0.0% C: 0.0%
smallpox vaccine contract

Valneva Receives Notice of European Commission’s Intent to Terminate COVID-19 Vaccine Purchase Agreement
Published: 2022-05-16 (Crawled : 06:00) - globenewswire.com
DVAX | $11.75 -0.76% -0.77% 1.4M

Health Technology

| 31.1% | O: 5.69% H: 6.75% C: 3.59%
covid-19 valneva vaccine

Valneva Provides Regulatory Update on its inactivated COVID-19 Vaccine Candidate
Published: 2022-04-25 (Crawled : 06:00) - globenewswire.com
DVAX | $11.75 -0.76% -0.77% 1.4M

Health Technology

| 16.78% | O: -6.95% H: 6.51% C: 6.19%
covid-19 valneva vaccine

Bavarian Nordic Announces Initiation of a Global Phase 3 Clinical Trial of its RSV Vaccine Candidate in Older Adults
Published: 2022-04-20 (Crawled : 06:00) - globenewswire.com
JNJ | News | $149.56 0.3% 0.0% 9.1M

Health Technology

| -17.01% | O: 1.06% H: 1.14% C: 0.91%
vaccine trial phase 3 order

Takeda Announces Approval of Nuvaxovid® COVID-19 Vaccine for Primary and Booster Immunization in Japan
Published: 2022-04-19 (Crawled : 06:00) - biospace.com/
TAK | News | $13.38 0.15% 0.9% 1.7M

Health Technology

| -9.83% | O: -2.23% H: 0.0% C: 0.0%
covid-19 nuvaxovid vaccine approval

Research Roundup: Why mRNA Vaccines are So Good Against Severe COVID-19 and More
Published: 2021-12-31 (Crawled : 06:00) - biospace.com/
JNJ | News | $149.56 0.3% 0.0% 9.1M

Health Technology

| -13.14% | O: 0.13% H: 0.09% C: -0.85%
covid-19 research covid vaccine

Nykode Therapeutics announces first subject dosed with its T cell focused next-generation SARS-CoV-2 vaccine candidate
Published: 2021-12-28 (Crawled : 06:00) - globenewswire.com
NKTR | News | $1.415 4.04% 3.89% 1.1M

Health Technology

| -90.99% | O: -0.91% H: 1.18% C: -1.31%
therapeutics cel sars-cov-2 vaccine t-cell

Valneva Signs Advance Purchase Agreement with Bahrain for Inactivated COVID-19 Vaccine VLA2001
Published: 2021-12-08 (Crawled : 06:00) - globenewswire.com
DVAX | $11.75 -0.76% -0.77% 1.4M

Health Technology

| -14.84% | O: 4.42% H: 2.08% C: -0.49%
valneva covid vla200 vaccine vla2001 covid-19

Mix-and-Match Vaccine Platform May Boost Immune Response & Duration
Published: 2021-12-03 (Crawled : 06:00) - biospace.com/
AMRS | $0.05 -21.88% -16.36% 47M

Process Industries